---
trial_id: 1547
discovery_date: 2022-07-29 15:03:31.687644
date: 2022-07-29 15:03:31.687644
title: "Methylphenidate modified release as treatment option of MS-associated fatigue. A single-center randomized double-blind placebo-controlled trial."
summary: |
  <p>EudraCT Number: 2012-003418-15<br />Sponsor Protocol Number: SSP<br />Sponsor Name: Medizinische Universität Wien<br />Start Date: 2012-10-23<br />Medical condition: Fatigue is a very common symptom in multiple sclerosis. Its management comprises nonpharmacologic approaches like exercise, cooling procedures and energy conservation programs and as second step ph...<br />Disease: <br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003418-15/AT">AT</a> (Prematurely Ended)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003418-15'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2012-003418-15<br />Sponsor Protocol Number: SSP<br />Sponsor Name: Medizinische Universität Wien<br />Start Date: 2012-10-23<br />Medical condition: Fatigue is a very common symptom in multiple sclerosis. Its management comprises nonpharmacologic approaches like exercise, cooling procedures and energy conservation programs and as second step ph...<br />Disease: <br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003418-15/AT">AT</a> (Prematurely Ended)</p>